Clinical Trials Browser

Phase 1/2 × anlotinib × 30 days × Clear all

NCT07320963 2026-03-20

Chidamide in Combination With Toripalimab and Anlotinib in Recurrent/Metastatic Nasopharyngeal Carcinoma.

Phase 1/2 Not yet recruiting

Nasopharyngeal Carcinoma